The PRIME project 2010

[Sly Saint]

The PRIME project: developing a patient evidence‐base
Sophie Staniszewska, DPhil (Oxon) BSc (Hons), 1 Sally Crowe, Post Graduate Diploma, 2 Douglas Badenoch, MSc, 3 Carol Edwards, BA MSc PhD, 4 Jan Savage, RN BSc (Hons) PhD, 5 and Will Norman, PhD MA (Hons) 6

Abstract
Background  The concept of evidence has become firmly rooted in health care, with most importance placed on the outcome of research in clinical and economic spheres. Much less emphasis is placed on the patient’s contribution to evidence which remains relatively vague, of low status and often difficult to integrate with other forms of knowledge.

Aim  This article proposes a concept of patient‐based evidence, to complement clinical and economic forms of evidence, and demonstrates one way in which it has been operationalized. The PRIME project developed a patient evidence‐base to capture the lived experience of individuals with myalgic encephalitis (ME) or chronic fatigue syndrome (CFS).

Design  Interviews were performed with 40 individuals with ME/CFS who varied in a range of demographic characteristics, including age, gender, and how severely affected individuals were.

Results  PRIME has developed a patient evidence‐base which has an extensive array of experiences data to provide researchers, clinicians and others with an in‐depth insight into the lived experience of ME/CFS that can be used and analysed. Data are grouped into a wide range of themes, which can be downloaded and used in a variety of ways as a source of evidence to enable understanding of the lived experience of ME/CFS and so contribute to the development of a more patient‐focused research agenda in ME/CFS.

Conclusions  While patient‐based evidence used in the PRIME Project provides a useful start, further work is required to develop this area conceptually and methodologically, particularly in relation to how patient‐based evidence can be considered alongside clinical and economic evidence.

Acknowledgements
We are grateful to the participation of all the individuals who were interviewed for this study. We are also grateful to the advisory group who have been an integral part of this study. They include: Catriona Courtier (Network MESH), Colin Barton (Sussex and Kent ME/CFS Society), Esther Crawley (Royal United Hospital, Bath), Jane Colby (Young ME Sufferers Trust), Jude Rogers (Crowe Associates), Ken Manley (CHROME), Kirstie Haywood (RCN Institute), Maria Shortis (Action for ME), Mary Jane Willows (Association of Young People and ME (AYME), Ray Gibbons (CHROME), Sarah Chapman, RCN Institute, Sarah Perkins (Medical Research Council), Sylvia Morgan (Network MESH), Trevor Wainright (Carer), Vivienne Parry (GUS Charitable Trust). We are also grateful for the funding, support and encouragement we received from the GUS Charitable Trust and particularly to its Administrator, Vivienne Parry who was integrally involved in this study and in the advisory group.

Does this still exist? (I haven't read all of it)

 

[Esther12]

I'd didn't see any Prime stuff still on-line. If we had an address we could probably find info at: https://web-beta.archive.org/

Vivienne Parry (GUS Charitable Trust). We are also grateful for the funding, support and encouragement we received from the GUS Charitable Trust and particularly to its Administrator, Vivienne Parry who was integrally involved in this study and in the advisory group.

Parry did this embarrassing defence of PACE for AYME: http://www.meassociation.org.uk/201...cience-writer-and-broadcaster-vivienne-parry/

 

[MEMarge]

Jane Colby at TYMES Trust would probably know what, if anything is ongoing